Report Detail

Request for Sample of this report

Pharma & Healthcare Global Organ Transplant Immunosuppressant Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4528641
    • |
  • 13 April, 2023
    • |
  • Global
    • |
  • 107 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Immunosuppressants are a class of drugs that suppress the immune response through various mechanisms. In organ transplantation, immunosuppressants are used to prevent the body from either recognition or attacking the foreign organ via various immune responses. They should only be used under the supervision of appropriately trained and experienced staff.
According to our (Global Info Research) latest study, the global Organ Transplant Immunosuppressant market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In China, Organ Transplant Immunosuppressant key players include Roche, Astellas Pharma Inc., Huadong Pharmaceutical, Novartis, etc.
This report is a detailed and comprehensive analysis for global Organ Transplant Immunosuppressant market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Organ Transplant Immunosuppressant market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Organ Transplant Immunosuppressant market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Organ Transplant Immunosuppressant market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Organ Transplant Immunosuppressant market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Organ Transplant Immunosuppressant
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Organ Transplant Immunosuppressant market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Astellas Pharma Inc., Huadong Pharmaceutical, Novartis and Catalent Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Organ Transplant Immunosuppressant market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tacrolimus
Mycophenolate Mofetil
Cyclosporin
Others
Market segment by Application
Liver Transplant
Kidney Transplant
Heart Transplant
Other Organ Transplant
Major players covered
Roche
Astellas Pharma Inc.
Huadong Pharmaceutical
Novartis
Catalent Pharma
Cinkate Corporation
Cilag
Genzyme
Changzhou Pharm
North China Pharmaceutical Group Corporation
SL PHARM
Livzon Pharmaceutical Group Inc.,
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Organ Transplant Immunosuppressant product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Organ Transplant Immunosuppressant, with price, sales, revenue and global market share of Organ Transplant Immunosuppressant from 2018 to 2023.
Chapter 3, the Organ Transplant Immunosuppressant competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Organ Transplant Immunosuppressant breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Organ Transplant Immunosuppressant market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Organ Transplant Immunosuppressant.
Chapter 14 and 15, to describe Organ Transplant Immunosuppressant sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Organ Transplant Immunosuppressant
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Organ Transplant Immunosuppressant Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Tacrolimus
    • 1.3.3 Mycophenolate Mofetil
    • 1.3.4 Cyclosporin
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Organ Transplant Immunosuppressant Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Liver Transplant
    • 1.4.3 Kidney Transplant
    • 1.4.4 Heart Transplant
    • 1.4.5 Other Organ Transplant
  • 1.5 Global Organ Transplant Immunosuppressant Market Size & Forecast
    • 1.5.1 Global Organ Transplant Immunosuppressant Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Organ Transplant Immunosuppressant Sales Quantity (2018-2029)
    • 1.5.3 Global Organ Transplant Immunosuppressant Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Organ Transplant Immunosuppressant Product and Services
    • 2.1.4 Roche Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Roche Recent Developments/Updates
  • 2.2 Astellas Pharma Inc.
    • 2.2.1 Astellas Pharma Inc. Details
    • 2.2.2 Astellas Pharma Inc. Major Business
    • 2.2.3 Astellas Pharma Inc. Organ Transplant Immunosuppressant Product and Services
    • 2.2.4 Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Astellas Pharma Inc. Recent Developments/Updates
  • 2.3 Huadong Pharmaceutical
    • 2.3.1 Huadong Pharmaceutical Details
    • 2.3.2 Huadong Pharmaceutical Major Business
    • 2.3.3 Huadong Pharmaceutical Organ Transplant Immunosuppressant Product and Services
    • 2.3.4 Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Huadong Pharmaceutical Recent Developments/Updates
  • 2.4 Novartis
    • 2.4.1 Novartis Details
    • 2.4.2 Novartis Major Business
    • 2.4.3 Novartis Organ Transplant Immunosuppressant Product and Services
    • 2.4.4 Novartis Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Novartis Recent Developments/Updates
  • 2.5 Catalent Pharma
    • 2.5.1 Catalent Pharma Details
    • 2.5.2 Catalent Pharma Major Business
    • 2.5.3 Catalent Pharma Organ Transplant Immunosuppressant Product and Services
    • 2.5.4 Catalent Pharma Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Catalent Pharma Recent Developments/Updates
  • 2.6 Cinkate Corporation
    • 2.6.1 Cinkate Corporation Details
    • 2.6.2 Cinkate Corporation Major Business
    • 2.6.3 Cinkate Corporation Organ Transplant Immunosuppressant Product and Services
    • 2.6.4 Cinkate Corporation Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Cinkate Corporation Recent Developments/Updates
  • 2.7 Cilag
    • 2.7.1 Cilag Details
    • 2.7.2 Cilag Major Business
    • 2.7.3 Cilag Organ Transplant Immunosuppressant Product and Services
    • 2.7.4 Cilag Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Cilag Recent Developments/Updates
  • 2.8 Genzyme
    • 2.8.1 Genzyme Details
    • 2.8.2 Genzyme Major Business
    • 2.8.3 Genzyme Organ Transplant Immunosuppressant Product and Services
    • 2.8.4 Genzyme Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Genzyme Recent Developments/Updates
  • 2.9 Changzhou Pharm
    • 2.9.1 Changzhou Pharm Details
    • 2.9.2 Changzhou Pharm Major Business
    • 2.9.3 Changzhou Pharm Organ Transplant Immunosuppressant Product and Services
    • 2.9.4 Changzhou Pharm Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Changzhou Pharm Recent Developments/Updates
  • 2.10 North China Pharmaceutical Group Corporation
    • 2.10.1 North China Pharmaceutical Group Corporation Details
    • 2.10.2 North China Pharmaceutical Group Corporation Major Business
    • 2.10.3 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Product and Services
    • 2.10.4 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 North China Pharmaceutical Group Corporation Recent Developments/Updates
  • 2.11 SL PHARM
    • 2.11.1 SL PHARM Details
    • 2.11.2 SL PHARM Major Business
    • 2.11.3 SL PHARM Organ Transplant Immunosuppressant Product and Services
    • 2.11.4 SL PHARM Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 SL PHARM Recent Developments/Updates
  • 2.12 Livzon Pharmaceutical Group Inc.,
    • 2.12.1 Livzon Pharmaceutical Group Inc., Details
    • 2.12.2 Livzon Pharmaceutical Group Inc., Major Business
    • 2.12.3 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Product and Services
    • 2.12.4 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Livzon Pharmaceutical Group Inc., Recent Developments/Updates

3 Competitive Environment: Organ Transplant Immunosuppressant by Manufacturer

  • 3.1 Global Organ Transplant Immunosuppressant Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Organ Transplant Immunosuppressant Revenue by Manufacturer (2018-2023)
  • 3.3 Global Organ Transplant Immunosuppressant Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Organ Transplant Immunosuppressant by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Organ Transplant Immunosuppressant Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Organ Transplant Immunosuppressant Manufacturer Market Share in 2022
  • 3.5 Organ Transplant Immunosuppressant Market: Overall Company Footprint Analysis
    • 3.5.1 Organ Transplant Immunosuppressant Market: Region Footprint
    • 3.5.2 Organ Transplant Immunosuppressant Market: Company Product Type Footprint
    • 3.5.3 Organ Transplant Immunosuppressant Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Organ Transplant Immunosuppressant Market Size by Region
    • 4.1.1 Global Organ Transplant Immunosuppressant Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Organ Transplant Immunosuppressant Consumption Value by Region (2018-2029)
    • 4.1.3 Global Organ Transplant Immunosuppressant Average Price by Region (2018-2029)
  • 4.2 North America Organ Transplant Immunosuppressant Consumption Value (2018-2029)
  • 4.3 Europe Organ Transplant Immunosuppressant Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Organ Transplant Immunosuppressant Consumption Value (2018-2029)
  • 4.5 South America Organ Transplant Immunosuppressant Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Organ Transplant Immunosuppressant Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2029)
  • 5.2 Global Organ Transplant Immunosuppressant Consumption Value by Type (2018-2029)
  • 5.3 Global Organ Transplant Immunosuppressant Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2029)
  • 6.2 Global Organ Transplant Immunosuppressant Consumption Value by Application (2018-2029)
  • 6.3 Global Organ Transplant Immunosuppressant Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2029)
  • 7.2 North America Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2029)
  • 7.3 North America Organ Transplant Immunosuppressant Market Size by Country
    • 7.3.1 North America Organ Transplant Immunosuppressant Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Organ Transplant Immunosuppressant Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2029)
  • 8.2 Europe Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2029)
  • 8.3 Europe Organ Transplant Immunosuppressant Market Size by Country
    • 8.3.1 Europe Organ Transplant Immunosuppressant Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Organ Transplant Immunosuppressant Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Organ Transplant Immunosuppressant Market Size by Region
    • 9.3.1 Asia-Pacific Organ Transplant Immunosuppressant Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Organ Transplant Immunosuppressant Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2029)
  • 10.2 South America Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2029)
  • 10.3 South America Organ Transplant Immunosuppressant Market Size by Country
    • 10.3.1 South America Organ Transplant Immunosuppressant Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Organ Transplant Immunosuppressant Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Organ Transplant Immunosuppressant Market Size by Country
    • 11.3.1 Middle East & Africa Organ Transplant Immunosuppressant Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Organ Transplant Immunosuppressant Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Organ Transplant Immunosuppressant Market Drivers
  • 12.2 Organ Transplant Immunosuppressant Market Restraints
  • 12.3 Organ Transplant Immunosuppressant Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Organ Transplant Immunosuppressant and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Organ Transplant Immunosuppressant
  • 13.3 Organ Transplant Immunosuppressant Production Process
  • 13.4 Organ Transplant Immunosuppressant Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Organ Transplant Immunosuppressant Typical Distributors
  • 14.3 Organ Transplant Immunosuppressant Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Organ Transplant Immunosuppressant. Industry analysis & Market Report on Organ Transplant Immunosuppressant is a syndicated market report, published as Global Organ Transplant Immunosuppressant Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Organ Transplant Immunosuppressant market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,208.56
    		4,812.84
    		6,417.12
    		531,604.80
    		797,407.20
    		1,063,209.60
    		292,702.80
    		439,054.20
    		585,405.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo